14 10, 2025

hepatoMX Project Kickoff: TAmiRNA and You2Yourself Join Forces to Develop a Groundbreaking Urinary microRNA Diagnostic for Liver Disease

2025-10-14T08:25:31+02:00October 14th, 2025|biomarker, Biomarker Discovery, biomarkers, hepatoMX, Illumina NewSeq2000, microRNA services, microRNAs, miND, miND spike ins, NGS, sequencing, small RNA-sequencing, smallRNA|0 Comments

We are excited to announce the official start of the EUREKA Eurostars project hepatoMX — a three-year collaboration between You2Yourself (Y2Y), a Dutch company specializing in small RNA-based early disease detection, and TAmiRNA GmbH, an Austrian SME with expertise in microRNA biomarker discovery and diagnostic test development (hepatomiR®). The project officially started on April 1, 2025, and aims to revolutionize the early detection of metabolic liver disease. The hepatoMX project will leverage TAmiRNA’s clinical expertise in liver diagnostics and Y2Y’s unique Urimon cohort that captures the dynamics of disease development to deliver a validated diagnostic test utilizing a proprietary urinary microRNA biomarker panel to identify early-stage liver disease in a simple and non-invasive manner. This innovative approach [...]

9 10, 2025

Microvascular microRNA Signatures in Sepsis: A High-Resolution View

2025-10-09T10:29:18+02:00October 9th, 2025|biomarker, Biomarker Discovery, biomarkers, Illumina NewSeq2000, laser microdissection (LMD), microRNA services, microRNAs, miND, miND spike ins, NGS, sequencing, small RNA-sequencing, smallRNA|0 Comments

Sepsis drives profound microvascular injury, particularly in the kidney. But how do microRNAs (miRNAs) - the small regulators of gene expression - respond within distinct vascular compartments during this insult? A new study by Luxen et al.  published in Scientific Reports on October 2nd 2025 takes on this question using a clever methodological combination: laser microdissection (LMD) of microvascular subregions (arterioles, glomeruli, capillaries, postcapillary venules) followed by small RNA sequencing using TAmiRNA´s miND® workflow for highly sensitive and quantitative microRNA analysis. Why this approach matters Traditional microRNA profiling of whole tissues obscures spatial heterogeneity. With LMD, the authors could precisely isolate defined microvascular zones from kidney sections. Even with the tiny RNA yields from these isolated compartments, [...]

22 09, 2025

TAmiRNA @ GSEV 2025

2025-09-22T08:52:59+02:00September 22nd, 2025|biomarker, Biomarker Discovery, biomarkers, microRNAs, NGS, periprosthetic joint infections, small RNA-sequencing, Synovial fluid|Comments Off on TAmiRNA @ GSEV 2025

TAmiRNA Announces Gold Sponsorship of GSEV Autumn Meeting 2025 and Presentation by Matthias Hackl TAmiRNA, a pioneer in transcriptomics-based biomarker research, is proud to announce its participation as a Gold Sponsor at the GSEV Autumn Meeting 2025, hosted by the German Society for Extracellular Vesicles (GSEV). The annual conference will take place on September 25–26, 2025, at the Audimax of the University Hospital Essen. As part of the scientific program, Matthias Hackl (TAmiRNA) will deliver a presentation on Thursday, September 25, at 12:15 pm entitled: “Small RNA-sequencing (miND®) Enables Discovery of EV-specific MicroRNA Signatures to Support EV Therapeutics Development.” “Using miND®, we can robustly identify EV-specific microRNA signatures – a critical step toward enabling data-driven research and [...]

8 09, 2025

TAmiRNA @ EBJIS 2025

2025-09-17T11:35:44+02:00September 8th, 2025|biomarker, Biomarker Discovery, biomarkers, microRNAs, NGS, periprosthetic joint infections, small RNA-sequencing, Synovial fluid|Comments Off on TAmiRNA @ EBJIS 2025

TAmiRNA is proud to announce its participation at the upcoming European Bone and Joint Infection Society (EBJIS) Meeting 2025 in Ferrara, Italy. On Thursday, September 11, 2025 at 11:00 (Sala Emilia), Dr. Bernhard JH Frank will present groundbreaking new results from a collaborative study conducted with the Orthopaedic Hospital Speising and Dr. Jochen G. Hofstätter. The presentation is entitled: “Synovial fluid microRNA biomarkers enable accurate diagnosis of hip and knee periprosthetic joint infections.” Synovial fluid microRNA biomarkers for accurate PJI diagnosis Periprosthetic joint infection (PJI) is one of the most severe complications after hip and knee replacement surgery. Accurate and timely diagnosis remains a clinical challenge due to limited sensitivity and specificity of current diagnostic methods. In [...]

16 07, 2025

Webinar Announcement

2025-07-16T10:01:30+02:00July 16th, 2025|biomarker, Biomarker Discovery, biomarkers, FFPE, microRNAs, miND spike-in, NGS, small RNA-sequencing|Comments Off on Webinar Announcement

🔬 Join us For Our Upcoming Webinar with BioEcho Life Sciences In this session, we'll explore: Discover how TAmiRNA’s miND® small RNA-sequencing assay enables absolute quantification and quality control through synthetic spike-ins, making it a powerful tool for transcriptomic profiling in challenging samples. Learn about the BioEcho EchoLUTION FFPE RNA extraction kit, which preserves the integrity of small and large RNAs to maximize sensitivity and reproducibility in FFPE tissue analysis. See case studies demonstrating how integrated workflows—from RNA extraction to sequencing and bioinformatic analysis—support microRNA biomarker identification and mechanistic insights. Explore bioinformatic tools for analyzing small RNA-seq and multiomic datasets to uncover microRNA function, cellular origin, and regulatory networks. Whether you are working with archived tissue samples or liquid biopsies, [...]

26 06, 2025

Unlocking the Next Generation of Biomarkers: Introducing TAmiRNA’s New circRNA Analysis Service

2025-06-26T15:23:19+02:00June 26th, 2025|biomarker, Biomarker Discovery, biomarkers, circRNA analysis service, liquid biopsies, microRNAs, NGS, small RNA-sequencing|Comments Off on Unlocking the Next Generation of Biomarkers: Introducing TAmiRNA’s New circRNA Analysis Service

The world of non-coding RNAs is continually expanding, revealing new layers of biological complexity and therapeutic potential. Among the most exciting discoveries are circular RNAs (circRNAs). Unlike their linear counterparts, circRNAs form covalently closed loops, granting them remarkable stability and unique functions in gene regulation. This intrinsic stability, coupled with their presence in biofluids, positions circRNAs as powerful new candidates for biomarker discovery and novel therapeutic targets. The Challenge of CircRNA Analysis from Biofluids Despite their immense promise, accurately isolating and quantifying circRNAs, especially from challenging biofluid samples like plasma and serum, has presented significant technical hurdles. These samples typically contain very low concentrations of circRNAs alongside a vast excess of highly abundant linear RNAs (like ribosomal [...]

8 05, 2025

Transcriptomics Webinar Announcement

2025-05-08T10:42:15+02:00May 8th, 2025|biomarker, Biomarker Discovery, biomarkers, microRNAs, NGS, small RNA-sequencing|Comments Off on Transcriptomics Webinar Announcement

🔬 Join us for an insightful transcriptomics webinar where we will delve into cutting-edge strategies for biomarker discovery, basic research, and translational applications. Whether you're focused on diagnostics or overcoming the challenges of low-input sample analysis, this webinar is designed for you! Title: Harnessing Transcriptomics: microRNA and mRNA analysis for Biomarker Discovery, Basic Research, and Translational Applications What to Expect: Comprehensive Transcriptomics Sequencing Services tailored to your research needs Insights into Biomarker Discovery, driving breakthrough advancements in diagnostics Strategies to overcome challenges with low-input samples, including biofluids and extracellular vesicles Opportunity to connect with our experts to discuss your transcriptomics goals and potential collaborations 📅 Date: 28.05.2025 🕒 Time: 13:00 -14:00 CET Presentation by Matthias Hackl, TAmiRNA GmbH [...]

27 03, 2025

EVscale™ and TAmiRNA at ISEV Vienna, April 24-27, 2025

2025-03-27T10:53:51+01:00March 27th, 2025|biomarker, biomarkers, Evercyte, EVscale, extracellular vesicle, microRNAs, Personalized medicine, smallRNA|Comments Off on EVscale™ and TAmiRNA at ISEV Vienna, April 24-27, 2025

We are thrilled to announce that TAmiRNA, Evercyte, and Phoenestra have united to form EVscale™, a powerful collaboration dedicated to providing comprehensive solutions for extracellular vesicle (EV) research, diagnostic, and therapeutic development. We will be exhibiting at the prestigious ISEV (International Society for Extracellular Vesicles) Conference in Vienna from April 24-27, 2025, and we invite you to visit us at Booth B13. The EV Scale platform is designed to streamline every step of your EV workflow, catering to both therapeutic development and sophisticated omics-based biomarker discovery. Leveraging the unique expertise of each partner, we offer an integrated approach that encompasses: Optimized EV Production for Therapeutics: Utilizing a range of high-quality mesenchymal stromal cell (MSC) lines from Evercyte, [...]

20 02, 2025

TAmiRNA and Medical University of Vienna Advance Liver Surgery Safety with hepatomiR®

2025-02-20T08:56:56+01:00February 20th, 2025|biomarker, biomarkers, CE-IVD, hepatomiR kit, Liver disease, microRNAs, MUW, Personalized medicine, smallRNA|Comments Off on TAmiRNA and Medical University of Vienna Advance Liver Surgery Safety with hepatomiR®

TAmiRNA has joined forces with the Medical University of Vienna to develop an innovative microRNA test (hepatomiR®) to improve safety in liver surgery. The pioneering qPCR-based test is founded on original research by two of the university’s associate professors, Dr. Alice Assinger, Head of the Vienna Platelet Lab, and Dr. Patrick Starlinger, who heads the university’s TELL Translational and Experimental Liver Laboratory. Their work on the mechanisms of circulating microRNAs complements original work done by TAmiRNA over the past decade. Urgent medical need This work has resulted in an easy-to-use CE-IVD-certified qPCR test for standardized determination of hepatocyte- and endothelial-derived microRNAs. The individual miRNA levels are converted into a liver function score (P-Score) to ascertain a patient´s [...]

5 02, 2025

7Bioscience and TAmiRNA collaborate to expand access to our cutting-edge transcriptomics services

2025-02-04T11:11:02+01:00February 5th, 2025|biomarker, biomarkers, microRNA services, microRNAs, sequencing, smallRNA|Comments Off on 7Bioscience and TAmiRNA collaborate to expand access to our cutting-edge transcriptomics services

We are delighted to welcome 7Bioscience as the new distribution partner of TAmiRNA GmbH! With a strong track record in clinical and research molecular biology, 7Bioscience will support to offer TAmiRNA’s innovative service solutions to a broader audience. This partnership will enhance accessibility to our cutting-edge transcriptomics analysis. We look forward to a successful collaboration with 7Bioscience and the opportunities this partnership will bring!

Go to Top